| Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS … YL Wu, D Planchard, S Lu, H Sun, N Yamamoto, DW Kim, DSW Tan, ... Annals of Oncology 30 (2), 171-210, 2019 | 271 | 2019 |
| Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative … K Park, J Vansteenkiste, KH Lee, G Pentheroudakis, C Zhou, K Prabhash, ... Annals of Oncology 31 (2), 191-201, 2020 | 82 | 2020 |
| Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study GF Ho, CS Chai, A Alip, MIA Wahid, MM Abdullah, YC Foo, SH How, ... BMC cancer 19, 1-11, 2019 | 43 | 2019 |
| LBA14 Amivantamab plus lazertinib vs osimertinib as first-line treatment in patients with EGFR-mutated, advanced non-small cell lung cancer (NSCLC): Primary results from … BC Cho, E Felip, AI Spira, N Girard, JS Lee, SH Lee, YV Ostapenko, ... Annals of Oncology 34, S1306, 2023 | 34 | 2023 |
| Treatment outcome for head and neck squamous cell carcinoma in a developing country: university Malaya medical centre, Malaysia from 2003-2010 YF Wong, MM Yusof, WZW Ishak, A Alip, VCE Phua Asian Pacific Journal of Cancer Prevention 16 (7), 2903-2908, 2015 | 17 | 2015 |
| Management of advanced prostate cancer in a middle‐income country: real‐world consideration of the Advanced Prostate Cancer Consensus Conference 2017 M Saad, A Alip, J Lim, MM Abdullah, FLT Chong, CB Chua, F Ismail, ... BJU international 124 (3), 373-382, 2019 | 12 | 2019 |
| Prognostic factors in patients with non-small cell lung carcinoma and brain metastases: a Malaysian perspective WH Tang, A Alip, M Saad, VCE Phua, H Chandran, YH Tan, YY Tan, ... Asian Pacific Journal of Cancer Prevention 16 (5), 1901-1906, 2015 | 12 | 2015 |
| Predictors of Acquired T790M Mutation in Patients Failing First- or Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors CS Chai, CK Liam, ME Poh, DBL Ong, YK Pang, PL Cheah, GF Ho, A Alip Cancer management and research, 5439-5450, 2020 | 10 | 2020 |
| Effectiveness of decision aid in men with localized prostate cancer: a multicenter randomized controlled trial at tertiary referral hospitals in an Asia Pacific country NB Jalil, PY Lee, MZ Nor Afiah, KL Abdullah, FNSM Azizi, NNSA Rassip, ... Journal of Cancer Education, 1-10, 2022 | 5 | 2022 |
| Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience NK Abd Ghafar, A Alip, TA Ong, NY Yap, M Saad Journal of Cancer Research and Therapeutics 14 (6), 1303-1311, 2018 | 5 | 2018 |
| Barriers of and strategies for shared decision‐making implementation in the care of metastatic breast cancer: A qualitative study among patients and healthcare professionals in … PY Lee, AT Cheong, SS Ghazali, AA Rashid, SC Ong, SY Ong, A Alip, ... Health Expectations 25 (6), 2837-2850, 2022 | 4 | 2022 |
| Dosage-dependent reduction of macular pigment optical density in female breast cancer patients receiving tamoxifen adjuvant therapy IL Lim, AVP Loo, V Subrayan, TF Khang, MH See, A Alip, NAM Taib The Breast 39, 117-122, 2018 | 4 | 2018 |
| The efficacy and tolerability of scalp cooling in preventing chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy … M Saad, FLT Chong, AZ Bustam, GF Ho, RA Malik, WZW Ishak, VCE Phua, ... Indian journal of cancer 55 (2), 157-161, 2018 | 4 | 2018 |
| Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: real‐world experience in the southeast … J Lim, A Amantakul, N Shariff, B Lojanapiwat, A Alip, TA Ong, ... Cancer medicine 9 (13), 4613-4621, 2020 | 3 | 2020 |
| Capecitabine pattern of usage, rate of febrile neutropaenia and treatment related death in asian cancer patients in clinical practice VCE Phua, WQ Wong, PL Tan, AZ Bustam, M Saad, A Alip, WZW Ishak Asian Pacific Journal of Cancer Prevention 16 (4), 1449-1453, 2015 | 3 | 2015 |
| Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel FAB Schutz, E Sirachainan, S Kuppusamy, NTT Hoa, T Dejthevaporn, ... Therapeutic Advances in Medical Oncology 13, 1758835920985464, 2021 | 2 | 2021 |
| Single vs multiple fraction palliative radiotherapy for uncomplicated painful bone metastases treated at University of Malaya Medical Centre: A single institutional Malaysian … IS Duraisamy, M Saad, A Alip Aging Medicine 1 (2), 133-140, 2018 | 2 | 2018 |
| Practical updates in medical therapy for advanced and metastatic renal cell carcinoma NY Yap, WT Khoo, K Perumal, KA Ng, R Rajandram, A Alip, M Saad, ... Urological Science 29 (3), 120-128, 2018 | 2 | 2018 |
| Risk of treatment related death and febrile neutropaenia with first line palliative chemotherapy for de novo metastatic breast cancer in clinical practice in a middle resource … CE Phua, WH Tang, MM Yusof, M Saad, A Alip, MH See, NA Taib Asian Pacific Journal of Cancer Prevention 15 (23), 10263-10266, 2015 | 2 | 2015 |
| LBA10 Amivantamab plus lazertinib vs osimertinib as first-line treatment among Asian patients with EGFR-mutated, advanced non-small cell lung cancer (NSCLC): MARIPOSA subgroup … S Lu, BC Cho, JS Lee, SH Lee, P Danchaivijitr, B Liu, A Alip, H Xiong, ... Annals of Oncology 34, S1661, 2023 | 1 | 2023 |
